{
  "id": 10568440,
  "title": "Meta platforms CEO Mark Zuckerberg sells $21.36m in stock",
  "url": "https://urgent.news/2026/09/29/meta-platforms-ceo-mark-zuckerberg-sells-21-36m-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-29T00:16:07.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/meta-platforms-ceo-mark-zuckerberg-sells-2136m-in-stock-93CH-4921446"
  },
  "original_language": "en",
  "account": "MENLO PARK, CA – Meta Platforms, Inc. CEO Mark Zuckerberg disclosed the sale of approximately $21.36 million worth of company shares on September 24, 2026. The transactions consisted of 17,140 shares of Class A Common Stock, which were sold through CZI Holdings, LLC, an entity with Zuckerberg as its trustee. The sales happened near META’s 52-week high of $779.82, although the stock has since dropped to $715.62. According to InvestingPro analysis, META is currently undervalued relative to its Fair Value. The sales were made under a Rule 10b5-1 trading plan adopted on January 31, 2026, and took place at prices between $775.00 and $779.80 per share. Separately, Chan Zuckerberg Biohub, Inc., an entity over which Zuckerberg has sole voting and investment power, sold 10,334 shares of Class A Common Stock, also under a Rule 10b5-1 trading plan adopted on January 31, 2026. These sales occurred at the same price range as the previous transaction and amounted to approximately $8,034,107. The stock's recent surge of 36% resulted in META shares being overbought, according to InvestingPro Tips. Notably, CZI Holdings, LLC also acquired an equivalent number of Class B Common Stock shares through a conversion, as Class B shares are convertible into Class A shares on a one-for-one basis.",
  "summary": null,
  "key_points": [
    "Meta CEO Mark Zuckerberg sold $21.36m in stock on September 24, 2026",
    "Transactions involved 17,140 Class A shares at $775-$779.80 per share",
    "CZI Holdings, LLC trustee sold shares; META undervalued per InvestingPro"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Monopar Therapeutics CEO Robinson sells $2.5m in stock",
        "url": "https://urgent.news/2026/09/29/monopar-therapeutics-ceo-robinson-sells-2-5m-in-stock",
        "published": "2026-09-29T01:15:59.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}